PROCEPT BioRobotics Corporation Increase (Decrease) in Other Operating Assets
PROCEPT BioRobotics Corporation (PRCT) reported Increase (Decrease) in Other Operating Assets of $835.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-05
- PROCEPT BioRobotics Corporation increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $404.00K, a 47.53% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $431.00K, a 9.11% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $922.00K, a 29.24% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $808.00K, a 405.00% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating assets for fiscal 2025 was $2.90M, a 76.85% increase from fiscal 2024.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating assets for fiscal 2024 was $1.64M, a 88.59% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating assets for fiscal 2023 was $868.00K, a 1601.96% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating assets for fiscal 2022 was $51.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $404.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $835.00K 10-Q · filed 2026-08-05 | $1.76M derived: sum of 3 quarters · filed 2026-08-05 | $2.56M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $431.00K 10-Q · filed 2026-04-30 | $1.35M derived: sum of 2 quarters · filed 2026-04-30 | $2.16M derived: sum of 3 quarters · filed 2026-04-30 | $2.93M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $922.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.73M derived: sum of 2 quarters · filed 2026-02-26 | $2.50M derived: sum of 3 quarters · filed 2026-08-05 | $2.90M 10-K · filed 2026-02-26 |
| 2025-09-30 | $808.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.58M derived: sum of 2 quarters · filed 2026-08-05 | $1.97M 10-Q · filed 2025-11-05 | $3.28M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $770.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.17M 10-Q · filed 2026-08-05 | $2.47M derived: sum of 3 quarters · filed 2026-08-05 | $2.63M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $395.00K 10-Q · filed 2026-04-30 | $1.70M derived: sum of 2 quarters · filed 2026-04-30 | $1.86M derived: sum of 3 quarters · filed 2026-04-30 | $1.79M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.46M derived: sum of 2 quarters · filed 2026-02-26 | $1.40M derived: sum of 3 quarters · filed 2026-02-26 | $1.64M 10-K · filed 2026-02-26 |
| 2024-09-30 | $160.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $93.00K derived: sum of 2 quarters · filed 2025-11-05 | $334.00K 10-Q · filed 2025-11-05 | $837.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $174.00K 10-Q · filed 2025-08-07 | $677.00K derived: sum of 3 quarters · filed 2026-02-26 | $961.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $241.00K 10-Q · filed 2025-05-02 | $744.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.03M derived: sum of 3 quarters · filed 2026-02-26 | $1.11M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $787.00K derived: sum of 2 quarters · filed 2026-02-26 | $868.00K derived: sum of 3 quarters · filed 2026-02-26 | $868.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $284.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | $365.00K derived: sum of 2 quarters · filed 2024-10-28 | $365.00K 10-Q · filed 2024-10-28 | $214.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $81.00K 10-Q · filed 2024-08-02 | -$70.00K derived: sum of 3 quarters · filed 2025-02-27 | -$170.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | -$151.00K derived: sum of 2 quarters · filed 2025-02-27 | -$251.00K derived: sum of 3 quarters · filed 2025-02-27 | |
| 2022-12-31 | -$151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$251.00K derived: sum of 2 quarters · filed 2025-02-27 | $51.00K 10-K · filed 2025-02-27 | |
| 2022-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $202.00K 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $302.00K 10-Q · filed 2023-07-28 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |